Your browser doesn't support javascript.
loading
Disseminated superficial actinic porokeratosis treated with ingenol mebutate gel 0.05.
Anderson, Isabella; Routt, Ethan T; Jim On, Shelbi C.
Afiliación
  • Anderson I; McGill University, Montreal, Quebec, Canada.
  • Routt ET; Department of Dermatology, Icahn School of Medicine at Mount Sinai, New York, New York, USA.
  • Jim On SC; Department of Dermatology, Icahn School of Medicine at Mount Sinai, New York, New York, USA.
Cutis ; 99(3): E36-E39, 2017 Mar.
Article en En | MEDLINE | ID: mdl-28398427
ABSTRACT
Disseminated superficial actinic porokeratosis (DSAP) is a chronic condition characterized by numerous atrophic papules and patches with a distinctive peripheral keratotic ridge, typically found on sun-exposed areas. Treatment of DSAP is warranted not only for cosmetic and symptomatic benefits but also to prevent malignant transformation. Successful treatment of DSAP often is difficult and frequently requires the use of multiple modalities. Ingenol mebutate gel 0.05% is a topical medication primarily used for the treatment of actinic keratosis (AK) by inducing cell death. We report a case of DSAP treated effectively with ingenol mebutate gel 0.05%.
Asunto(s)
Buscar en Google
Colección: 01-internacional Banco de datos: MEDLINE Asunto principal: Poroqueratosis / Fármacos Dermatológicos / Diterpenos Límite: Adult / Female / Humans Idioma: En Revista: Cutis Año: 2017 Tipo del documento: Article País de afiliación: Canadá
Buscar en Google
Colección: 01-internacional Banco de datos: MEDLINE Asunto principal: Poroqueratosis / Fármacos Dermatológicos / Diterpenos Límite: Adult / Female / Humans Idioma: En Revista: Cutis Año: 2017 Tipo del documento: Article País de afiliación: Canadá